Results 151 to 160 of about 106,739 (248)

Characterization of apomucin expression in intrahepatic cholangiocarcinomas and their precursor lesions: An immunohistochemical study [PDF]

, 1996
Motoko Sasaki
openalex   +1 more source

Whole Transcriptome Sequencing Analyzes the Interactions of mRNAs and ncRNAs in Cholangiocarcinoma. [PDF]

Cancer Med
Wang Q, Chen M, Zhang J, Feng C, Li H, Guo J, Sun Z, Feng Y.   +7 more
europepmc   +1 more source

CLDN18.2: a potential nanotherapeutic target for cholangiocarcinoma. [PDF]

Front Pharmacol
Huang Y, Ye Y, Yi T, Yuan C, Li D.
europepmc   +1 more source

Claudin 18.2: a promising actionable target in biliary tract cancers. [PDF]

ESMO Open
Angerilli V, Sacchi D, Rizzato M, Gasparello J, Ceccon C, Sabbadin M, Niero M, Bergamo F, Cillo U, Franzina C, Luchini C, Dei Tos AP, Lonardi S, Fassan M.   +13 more
europepmc   +1 more source

Dual blockage of PI3K-mTOR and FGFR induced autophagic cell death in cholangiocarcinoma cells

Heliyon
Purpose: To assess the impact of concurrent inhibition of the FGFR and PI3K/mTOR signaling pathways on oncogenic characteristics in cholangiocarcinoma (CCA) cells, including proliferation, autophagy, and cell death.
Narumon Mahaamnad, Piman Pocasap, Veerapol Kukongviriyapan, Laddawan Senggunprai, Auemduan Prawan, Sarinya Kongpetch   +5 more
doaj  

Pathological Complete Response after Pembrolizumab Treatment for Unresectable Perihilar Cholangiocarcinoma with High Microsatellite Instability: A Case Report. [PDF]

Surg Case Rep
Inokawa Y, Mizuno H, Yamada M, Kawakatsu S, Watanabe N, Onoe S, Mizuno T, Okayama K, Okumura F, Kajikawa M, Ebata T.   +10 more
europepmc   +1 more source

Improvement of survival outcomes of cholangiocarcinoma by ultrasonography surveillance: Multicenter retrospective cohorts

Heliyon
Background: Most cholangiocarcinoma (CCA) patients present with late stage of disease because of the difficulty to diagnosis at an early stage, resulting in poor survival of CCA patients.
Nittaya Chamadol, Vallop Laopaiboon, Apiwat Jareanrat, Vasin Thanasukarn, Tharatip Srisuk, Vor Luvira, Poowanai Sarkhampee, Winai Ungpinitpong, Phummarat Khamvijite, Yutthapong Chumnanua, Nipath Nethuwakul, Passakorn Sodarat, Samrit Thammarit, Anchalee Techasen, Jaruwan Thuanman, Chaiwat Tawarungruang, Bandit Thinkhamrop, Prakasit Sa-Ngiamwibool, Watcharin Loilome, Piya Prajumwongs, Attapol Titapun   +20 more
doaj  

Phase 2 study of combination SPI-1620 with docetaxel as second-line advanced biliary tract cancer treatment [PDF]

, 2017
A Rai, AG Tolcher, AX Zhu, Caio Max S Rocha-Lima, David Portnoy, DP Brooks, E Gabriela Chiorean, E Suzuki, J Albores-Saavedra, J Nelson, J Valle, JE Rogers, JF Guion-Dussere, Jitendra Gandhi, L Goyal, M Yanagisawa, Manik Amin, NV Rajeshkumar, NV Rajeshkumar, P Papakostas, R Pazdur, Richard Kim, RK Jain, RL Siegel, S He, SC Lee, SY Oh, T Sasaki, T Walter, Tao Song, William P Harris   +30 more
core   +3 more sources

Detecting plasma SHOX2, HOXA9, SEPTIN9, and RASSF1A methylation and circulating cancer cells for cholangiocarcinoma clinical diagnosis and monitoring. [PDF]

World J Gastrointest Oncol
Yu J, Liu QC, Lu SY, Wang S, Zhang H.
europepmc   +1 more source

Allelic loss in human intrahepatic cholangiocarcinoma: Correlation between chromosome 8p22 and tumor progression [PDF]

, 2000
Jun Kawaki, Masaru Miyazaki, Hiroshi Itô, Koji Nakagawa, Hiroaki Shimizu, Hiroyuki Yoshidome, Katsuhiro Uzawa, Hideki Tanzawa, Nobuyuki Nakajima   +8 more
openalex   +1 more source